Effects of MTN Enzyme Deficiency on \u3ci\u3eE. coli\u3c/i\u3e O157:H7 Growth and Virulence by Knippel, Reece
EFFECTS OF MTN ENZYME DEFICIENCY ON E. COLI O157:H7 GROWTH AND 
VIRULENCE 
 
 
 
 
by 
Reece Knippel 
 
 
 
 
 
A thesis 
submitted in partial fulfillment 
of the requirements for the degree of 
Master of Science in Chemistry 
Boise State University 
 
May 2013 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2013 
Reece Knippel 
ALL RIGHTS RESERVED 
BOISE STATE UNIVERSITY GRADUATE COLLEGE 
 
 
DEFENSE COMMITTEE AND FINAL READING APPROVALS 
 
 
of the thesis submitted by 
 
 
Reece Knippel 
 
 
Thesis Title: Effects of MTN Enzyme Deficiency on E. coli O157:H7 Growth and 
Virulence 
 
Date of Final Oral Examination: 15 March 2013 
 
The following individuals read and discussed the thesis submitted by student Reece 
Knippel, and they evaluated his presentation and response to questions during the final 
oral examination.  They found that the student passed the final oral examination.  
 
Ken Cornell, Ph.D.    Chair, Supervisory Committee 
 
Kristen Mitchell, Ph.D.   Member, Supervisory Committee 
 
Rajesh Nagarajan, Ph.D.   Member, Supervisory Committee 
 
The final reading approval of the thesis was granted by Ken Cornell, Ph.D., Chair of the 
Supervisory Committee.  The thesis was approved for the Graduate College by John R. 
Pelton, Ph.D., Dean of the Graduate College 
iv 
DEDICATION 
I dedicated this thesis to those who never gave up on me. It has been a chaotic and 
insane ride these last couple years. I am thankful for all the love and support given to me 
by family, friends, and classmates. Let the completion of this thesis mark the end of one 
chapter of my life, as well as the beginning of an exciting new one.  
v 
ACKNOWLEDGEMENTS 
The first acknowledgement is to Dr. Ken Cornell who allowed me to work in his 
lab for over four years and was the best mentor I could have wanted. I would like to 
acknowledge Dr. Haiqing Sheng at the University of Idaho for providing the MTN KO 
strain in E. coli O157:H7 as this work would not have been possible without this strain. I 
would also like to thank the members of my graduate committee, Dr. Kristen Mitchell 
and Dr. Rajesh Nagarajan for providing feedback and support for this work. Other thanks 
are due to the late Dr. Robert Kadner at the University of Virginia for supplying the 
RK4353 strains, and Dr. Brett Finlay at the University of British Columbia for supplying 
the α-EspB and α-Tir antibodies. I also thank Ms. Raquel Brown for her technical 
assistance with the confocal microscopy. Finally, I would like to thank all of the 
undergraduates who assisted on this thesis, especially Allison Eberly for optimizing 
biofilm production and Meagan Boll for the analysis and sorting of the proteomic data. 
I would also like to acknowledge all of the funding sources that supported this 
research, especially Idaho INBRE (P20RR016454). Other sources of funding include 
grants from MSTMRI, Merck/AAAS, NSF REU (CHE-1005159), NSF MRI (CHE-
0923535), and Dept. of Defense (MRMCW81XWH-09-0588).  
vi 
ABSTRACT 
The bacterial enzyme Methylthioadenosine/S-adenosylhomocysteine (MTA/SAH) 
nucleosidase (MTN) is involved in methionine and adenine salvage from the by-products 
of S-adenosylmethionine (SAM, AdoMet) dependent reactions. MTN plays a critical role 
in alleviating product inhibition of SAM dependent reactions, including methylation 
reactions and the synthesis of polyamines, vitamins, and autinducer signals. Due to its 
absence from humans and its importance to bacterial metabolism, MTN is a potential 
target for the development of novel antibiotics to treat microbial infections. In this study, 
a MTN gene knock-out (MTN KO) strain of the pathogen E. coli O157:H7 was created to 
study the impact of MTN activity on bacterial growth, virulence, and autoinducer-
dependent events; and to model the effects that would be expected from complete 
pharmacologic interruption of enzyme activity.  E. coli O157:H7 was chosen as the topic 
of study since it is a serious gram-negative pathogen responsible for severe diarrhea that 
can progress to cause hemolytic uremic syndrome (HUS), and factors influencing its 
virulence are well known.  
The MTN KO strain showed delayed growth, minimal biofilm production, and 
decreased in vitro virulence when compared to the parental wild type (WT) strain. 
Notably, the MTN KO strain showed a reduced ability to adhere to cultured mammalian 
cells. An analysis of virulence factor expression showed that the MTN KO strain secreted 
less Shiga-toxin, type-III secretory proteins, and hemolysin activity than the parental WT 
strain.  Culture supplementation with autoinducer-2 precursor, 4,5-dihydroxy-2,3-
vii 
pentanedione (DPD) did not restore the growth or virulence of the MTN KO strain, 
suggesting that the virulence defect was not the result of a loss of autoinducer-2 
signaling. However, culture supplementation with lipoate, thiamine and biotin partially 
reconstituted the growth and virulence phenotypes of the KO strain to WT levels, 
indicating that altered vitamin-dependent metabolic activity played a role in the defect.  
The lipoate- and thiamine-dependent enzymes in the pyruvate dehydrogenase complex 
were overexpressed in the MTN KO strain, but the enzyme complex showed lower 
specific activity than the WT strain, suggesting that the ability to synthesize these 
vitamins was compromised in the KO strain. Other metabolic enzymes (lactate 
dehydrogenase, alcohol dehydrogenase, glutamate dehydrogenase) were found to have 
specific activities equal to the WT strain, thus providing release points for excess 
metabolites in the KO strain.  
This study provides support for MTN as a target for antibiotic treatment. Our 
results indicate that one mechanism by which MTN specific inhibitors could exert their 
antibiotic effect is by interrupting vitamin dependent processes, particularly in central 
carbon metabolism. While loss of MTN activity was not bactericidal in this case, the 
significant reduction in bacterial growth, biofilm formation and virulence suggests that 
the bacteria treated with MTN inhibitors could have increased susceptibility to traditional 
antibiotics and the host immune system responses. This supports the incorporation of 
MTN inhibitors into combination drug therapies with standard antibiotics.  Finally, the 
creation and analysis of a MTN KO strain provides a valuable tool to explore potential 
mechanisms of antibiotic action that can be used in comparative studies to examine the 
antimicrobial activities of future MTN inhibitors.  
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CHAPTER ONE: INTRODUCTION 
The development of antibiotics in the 19
th 
century revolutionized the field of 
medicine by dramatically improving the ability to treat life-threatening infections. Paul 
Erlich, who would become known as the “Father of Antibiotics,” first hypothesized that 
if a dye was selectively toxic to bacterial cells, but not to mammalian cells, it would cure 
all infections.
1
 After screening hundreds of dyes, Erlich discovered Salvarsan, the first 
synthetic antibiotic used specifically to treat syphilis. In 1929, Sir Alexander Fleming 
discovered that secreted products of the Penicillium mold could lyse Staphylococcus 
cells, which marked the first report of the antibacterial action of a natural fungal product.
2
   
Subsequently, the first widespread introduction of effective sulfonamides by 
Domagk in 1937 was closely followed by reports of the development of bacterial 
resistance.
3
 Resistance to sulfonamides, originally reported in the late 1930s, persists 
today.
2
 Bacterial resistance to penicillin was also reported by two members of the 
discovery team several years before its introduction as a therapeutic.
4
 Once penicillin was 
widely distributed in the 1940s and 1950s, drug-resistant strains expressing penicillinase 
(β-lactamase) activity became prevalent. To combat this, a widespread effort was made to 
develop synthetic penicillinase inhibitors and new generations of penicillin-based drugs 
that were resistant to earlier β lactamases.3 Invariably, the development and introduction 
of every antibiotic has been followed by eventual bacterial resistance. 
A more startling trend is that many bacterial pathogens associated with epidemics 
of human disease have evolved multiple drug resistances.
3
 The evolution of drug 
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resistance is encouraged by the misuse of antibiotics and the rapid adaptability of 
bacteria. Hospitals serve as spawning grounds for many of these drug resistant strains. 
The most prevalent example is methicillin-resistant Staphylococcus aureus (MRSA), 
which developed resistance to methicillin only three years after the introduction of this 
drug.
3
 With time, MRSA acquired multiple forms of drug resistance and developed into a 
major community-acquired pathogen. Since then, a variety of other superbugs have 
emerged, including carbenapem resistant Enterobacteriaceae (CRE). As standard forms 
of antibiotics are becoming obsolete, there is a potential for all pathogenic bacteria to 
resist antibiotic treatment. Thus, there exists a dire need for novel forms of antibiotics to 
either replace or revitalize older drugs in order to prevent a reversion to the pre-antibiotic 
age when every infection was potentially life threatening.  
S-adenosylmethionine Reactions 
S-adenosylmethionine (SAM) is an important nucleoside found in all living 
organisms where it serves as an active group donor in a vast array of metabolic and 
biosynthetic reactions.
5
 The main use of SAM is as the primary methyl group donor in 
methylation reactions of macromolecules and small molecules. Other metabolic fates of 
SAM include the synthesis of acylhomoserine lactones (autoinducer-1, AI-1), polyamine 
synthesis (spermidine, spermine, etc), and radical SAM reactions involved in vitamin 
synthesis (Figure 1). SAM is synthesized in the cytosol by methionine adenosyl-
transferase (MAT), which joins L-methionine to ATP and yields SAM, pyrophosphate 
and phosphate ion (Figure 2).
6
 This transfer creates a metastable sulfonium ion, providing 
a target for nucleophilic substitution reactions that allow the transfer of methyl-, 
propylamino-, and other functional groups from SAM. 
3 
 
 
 
Figure 1. S-adenosylmethionine metabolic reactions. SAM is used as a reagent in 
transmethlyations, polyamine synthesis, autoinducer synthesis, and radical SAM reactions. 
SAH, MTA, and 5‟dADO are toxic side products of these reactions. MTN is responsible for 
the hydrolysis of the glycosidic linkage between the adenine and the ribose sugar. The ultimate 
goal of these reactions is to allow salvage of both methionine and adenine. 
4 
 
 
Figure 2. Synthesis of SAM. SAM is synthesized in the cytosol by methionine 
adenosyltransferase (MAT), which joins L-methionine to ATP and yields SAM, 
pyrophosphate, and phosphate ion. 
 
SAM-dependent methyltranferase reactions are diverse and critical for survival 
(Figure 3). As an example, the methylation of cytosine in DNA regulates a variety of 
mammalian gene activities, somatic inheritance, and cellular differentiation.
7
 In bacteria, 
methylations are responsible for regulation of many processes, including motility, gene 
expression, and the bacterial cell cycle.
5
 SAM is also the major methyl donor for 
proteins, phospholipids, carbohydrates, and various other molecules. While a variety of 
reaction mechanisms are used in transferases, the byproduct of the all the reactions is S-
adenosylhomocystiene (SAH).
5  
 
Figure 3. SAM–dependent methyltransferase reaction. Generic representation of 
SAM acting as a methyl donor. SAH can act as a product inhibitor to these reactions. 
 
Polyamine and autoinducer syntheses are also SAM dependent and essential 
molecules for cell growth and communication. The byproduct in each reaction is 
methylthioadenosine (MTA). Spermidine is produced from the transfer of a 5‟ 
+ + + 
ATP Methionine SAM 
+ + 
SAM SAH 
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propylamine group from decarboxylated SAM to putrescine by spermidine synthase 
(Figure 4).
5,11
 Polyamines are fully protonated under physiological conditions and thus 
carry a positive charge that form ionic interactions with negatively charged nucleic acids, 
specific proteins, and phospholipids.
11
 It is known that the rate of DNA synthesis is 
decreased by polyamine deficiency. Polyamines also confer protective effects against 
apoptosis, and play a major role in protein synthesis.
11   
 
Figure 4. Polyamine synthesis. Spermidine synthase transfers the 5‟ propylamine group 
from decarboxylated SAM to putrescine to produce spermidine. MTA acts as a product 
inhibitor of this reaction.   
 
N-acylhomoserine lactones (AI-1) are synthesized from the donation of an acyl 
group from hexanoyl acyl carrier protein (ACP) to SAM.
5
 In this reaction, a cyclization 
occurs to form the internal lactone ring and MTA as a byproduct (Figure 5). 
 
Figure 5. Autoinducer-1 synthesis. AI-1 is synthesized from the donation of an acyl 
group from hexanoyl ACP to SAM by LasI MTA can act as a product inhibitor to this 
reaction.  
 
+ + 
dcSAM MTA Putrescine Spermidine 
SAM MTA AI-1 
+ + 
Acyl-ACP 
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SAM is also used as an oxidizing agent in radical SAM dependent reactions. The 
general reaction catalyzed by radical SAM enzymes occurs first by the reduction of the 
sulfonium by a coordinated iron-sulfur cluster.
9,10
 The newly formed radical abstracts a 
hydrogen from a substrate C-H bond (Figure 6).
11
 Products of this abstraction vary 
greatly and include anaerobic oxidations, sulfur insertions, isomerizations, ring 
formation, and unusual methylations.
5
 In addition to the formation of the desired product, 
methionine and 5‟-deoxyadenosine (5‟-dADO) are formed as byproducts that can be 
recycled back to form SAM.  
 
Figure 6. Radical SAM reaction. Reduction of the sulfonium occurs through 
coordination to an iron-sulfur cluster. The radical abstracts a hydrogen from a substrate 
C-H bond. Methionine and 5‟-dADO are formed as byproducts. 5‟-dADO can act as a 
product inhibitor to this reaction.   
 
Radical SAM reactions are important to the synthesis of secondary metabolites, 
vitamins, antibiotics, and assist with bacterial DNA repair. Biotin synthase is a radical 
SAM enzyme that catalyzes the substitution of a bridging sulfur atom for hydrogen in 
desthiobiotin to form the essential enzyme cofactor biotin.
12
 Lipoyl synthase is another 
radical SAM enzyme that catalyzes the final step in de novo biosynthesis of the lipoate 
cofactor by inserting two sulfur atoms into an 8-carbon-saturated fatty acyl chain.
14
 
+ + + 
SAM Methionine 5‟-dADO 5‟-dADO 
radical 
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Precursors of the cofactor thiamine are generated in several bacteria by the enzyme 
tyrosine lyase, a radical SAM enzyme.
13
 Overall, the radical SAM super family is 
currently composed of more than 2800 proteins involved in over 40 distinct biochemical 
transformations.
8
  
A regulatory characteristic of all of the above SAM dependent reactions is the 
susceptibility to product inhibition by SAH, MTA, and 5‟-dADO.5 SAH has been shown 
in vitro to inhibit a number of bacterial methyltransferases at low micromolar 
concentrations.
15,16
 Several reports have also shown that enzymatic degradation of SAH 
by MTA/SAH nucleosidase alleviates product inhibition of methylation reactions.
17,18
 
The nucleoside MTA has also been shown to be a potent inhibitor of polyamine synthase 
reactions at low micromolar concentrations.
19-21
 In addition, MTA inhibits 50% of 
autoinducer-1 synthase activity at concentrations as low as 5 µM.
21
 Lastly, 5‟-dADO and 
methionine were shown to inhibit biotin synthase, lipoyl synthase, and tyrosine lyase.
10 
In 
order to reduce product inhibition by these nucleosides, all organisms have developed 
efficient nucleosidases to catabolize them and salvage their constituent parts.   
Methylthioadenosine/S-adenosylhomocystiene Nucleosidase and the 
Methionine Salvage Pathway 
Methythioadenosine/S-adenosylhomocysteine nucleosidase (MTN) catalyzes the 
irreversible cleavage of MTA, SAH, and 5‟-dADO to adenine and the corresponding 
pentose, 5-methylthioribose (MTR), S-ribosylhomocysteine (SRH), and 5-deoxy-D-
ribose (5-dRIB), respectively.
5,22
 MTN exists as a 25-35 kD homodimer and is found in 
the methionine salvage pathway for the majority of bacteria (Figure 7).
5,22,24
 Specifically 
in 51 bacterial species, including pathogens with reductive genomic evolution, MTN is 
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responsible for metabolism of the three nucleotides.
23,25
 Other bacteria that contain 
relatively large genomes and exhibit complex metabolism use two enzymes to remove 
MTA and SAH independently.
26
 These organisms behave metabolically more like 
humans: a MTA phosphorylase converts MTA to 5-methythioribose-1-phosphate, while 
SAH hydrolase catabolizes SAH.
5
 This more restricted substrate specificity is proposed 
to allow more efficient metabolism to promote better survival in these organisms.
27,28  
 
Figure 7. Structure of the E. coli Methylthioadenosine/S-adenosylhomocysteine 
Nucleosidase. Ribbon representation of the E. coli MTN dimer viewed down the 
noncrystallographic two-fold axis. A molecule of the MTA analogue Formycin-A is 
shown bound in each active site. (adapted from Lee et al., 2001)
23 
 
The ultimate purpose of MTN is to catabolize growth inhibitory MTA, SAH, and 
5‟-dADO; and salvage the methionine and adenine, which are metabolically expensive to 
synthesize.
5
 The adenine is recycled back to purine nucleosides. The thiopentoses MTR 
and SRH require further enzymatic reactions to salvage the sulfur atom back into 
methionine (Figure 8).
5,29,30
 The conversion of MTR to methionine begins with the 
phosphorylation of MTR to MTR-1-phosphate (MTR-1-P) by MTR kinase.
29
 In bacteria 
that contain a complete salvage pathway, an additional four or five enzymatic steps 
(depending on the species) are required to convert MTR-1-P to methionine.
5
 Some 
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organisms such as E. coli, that live in sulfur rich environments do not salvage methionine 
and secrete MTR, instead.
32
   
To salvage methionine from SAH catabolism, the majority of bacteria use the 
enzyme LuxS to cleave the thiopentose S-ribosylhomocysteine (SRH) to produce 
homocysteine and 4,5-dihydroxy-2,3-pentadione, the precursor to autoinducer-2 (AI-2, 
Figure 9).
5
 Homocysteine is remethylated to form methionine using either cobalamin-
dependent (MetH) or cobalamin-independent (MetE) methionine synthases.
33,68
 
 
 
Figure 8. The methionine salvage pathway in bacteria. Dashed lines represent species 
variations.  (adapted from Sekowska et al., 2004).
25 
10 
 
 
Figure 9. Autoinducer-2 synthesis. LuxS cleaves SRH to produce homocysteine and 
4,5-dihydroxy-2,3-pentadione, which can then cyclize to form AI-2.   
 
MTN is a potential novel antibiotic target due to its critical involvement in 
microbial metabolism and its absence in humans. The first description of MTN enzyme 
activity was reported in 1963.
89
 In 1979, a study of MTA analogs was published that 
demonstrated that they were effective competitive inhibitors of MTN, and set the stage 
for further exploration of this enzyme as a chemotherapeutic target.
34
 This initial 
discovery lead to further studies on the development of substrate and transition-state 
analogs.
31,39,40
 Extensive crystallographic studies revealed MTN exists as a homodimer 
and established that enzyme-substrate interactions responsible for recognition and 
catalysis.
35-40
 Importantly, these studies revealed that the active site of each subunit 
contains a hydrophobic pocket involved in recognition of the 5‟ alkyl portion of the 
nucleoside that is partially composed of residues from the second subunit.
22,34-37
 The 
hydrolysis of the substrates is essentially irreversible and the acidic amino acid residues, 
Glu
12
, Glu
174
, and Asp
197
, involved in catalysis are highly conserved across species.
25,36,37
  
While substrates and transition states are similar between bacterial MTN and 
mammalian MTA phosphorylase (MTP), crystallographic studies also reveal distinct 
differences in the enzyme active sites. In MTN, the active site has a larger 5‟alkylthio 
binding pocket, which allows for recognition of SAH and other larger thionucleoside 
analogues than the active site of MTP.
35
 There are also surface charge differences in the 
SRH DPD AI-2 Homocysteine 
11 
 
region of the enzymes responsible for recognition of the 2‟hydroxyl-group on the 
nucleoside: MTP is positively charged, while MTN is negatively charged.
35
 Combined, 
these features suggest routes for directed drug design that would yield inhibitors capable 
of discriminating between the two enzymes.
5
 The majority of the work to develop 
specific selective inhibitors of MTN has been performed in Dr. Vern Schramm‟s lab at 
Albert Einstein College.
31,38-40,71
 These inhibitors are based on transition state structures 
for the substrate that would bind the enzyme active site with the highest affinity. Recent 
specific potent late transition stage MTA analogs with bulky 5‟ substitutions (DADMe-
immucillin 54: DADMe-immucillin 57) are selective inhibitors that bind with a thousand-
fold greater affinity (or more) to MTN than to MTP (Figure 10).
38-40
 However, most of 
the studies testing MTN transition state inhibitors as antibiotics in E. coli and other 
bacterial species have reported only modest activity, with IC50 values in the micromolar 
range or higher.
5
 It has been proposed that the transition state analogs failed to exert 
potent antibiotic effects due to poor drug permeability or transport into the cell.
39
 
However, in species that are purine auxotrophs, such as Borrelia burgdorferi, MTN 
inhibitors were more potent.
40
 Probably this is due to the greater need by these organisms 
to salvage methionine and purines, which makes them more sensitive to MTN 
interruption.
40
 
Despite rather poor antibiotic effects in E. coli, MTN transition state analogues 
have been shown to reduce AI-2 synthesis and biofilm formation.
39
 Thus, the inhibitors 
have been proposed to act more as interrupters of microbial autoinducer signaling than as 
direct bactericidal agents. This may be critically important since virulence, pathogenesis, 
and drug resistance are thought to be regulated (at least partially) by intercellular 
12 
 
communication. Interruption of bacterial communication represents a new paradigm for 
the development of antibiotics. These drugs could act less directly than traditional 
antibiotics (like penicillin) to kill bacteria. Instead, they could cause attenuation of the 
pathogen so that the host immune system could more effectively combat the infection.   
 
 
 
 
 
 
EARLY TRANSITION STATE ANALOGUES       
 
LATE TRANSITION STATE ANALOGUES 
MT-ImmA 
K
i
 
= 120 ± 5 pM  
5’d-Et-ImmA 
K
i
 
= 130 ± 12 pM  
MT-DADMe-ImmA 
K
i
 
= 86 pM  
BuT-DADMe-ImmA 
K
i
 
= 296 fM  
DADMe-ImmA 54 
K
i
 
= 64 pM  
DADMe-ImmA 57 
K
i
 
= 54 pM  
Figure 10. Early and late transition state analogues for MTN. Inhibitors of MTN 
contain a non-hydrolyzable linkage between the adenine and pentose moieties. The 
selectivity index for bacterial MTN can be up to a 1000 fold higher when compared 
to human MTP. All Ki values reported are for E. coli MTN and were obtained from 
the literature.
31, 37-40, 71 
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Quorum Sensing 
Quorum sensing (QS) is the process of bacterial cell to cell communication that 
involves production, detection, and response to extracellular signaling molecules known 
as autoinducers (AI).
45 
QS was originally discovered over 30 years ago in two 
bioluminescent bacterial species, Vibrio fischeri and Vibrio harveyi. In these species, 
light emission occurred only at high cell population density, when the accumulation of 
secreted AIs stimulated the expression of the structural operon luxCDABE, which 
encodes the light producing luciferase enzyme.
45
 Since this initial discovery, it has been 
reported that QS is responsible for an array of bacterial phenotypes and behaviors 
including sporulation, competence, antibiotic production, biofilm formation, and 
virulence factor secretion.
45 
While the regulatory components and molecular mechanisms of QS differ 
between bacterial species, three basic principles apply. First, all communicating bacteria 
produce AIs. When the population of a bacterial community is low, the AIs are in such 
low concentration that they are unable to stimulate a population-wide response. After the 
population reaches a high density, the additive amount of AIs produces a cumulative 
response. The second principle of QS is that receptors for AIs exist in the membrane or 
the cytoplasm of the responding cells. Lastly, AIs induce varied gene expression and 
stimulate production of additional AIs through a positive feedback loop to sponsor 
synchronous behavior in the cell population (Figure 11).
45 
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The mechanism of QS differs in Gram-positive and Gram-negative bacteria. In 
Gram-positive bacteria, small cyclic peptides (AIP) are used as signaling molecules while 
in Gram-negative bacteria small molecules such as acyl-homoserine lactones are used 
(Table 1). Staphylococcus aureus, a Gram-positive pathogen, utilizes AIPs to regulate the 
agr system that controls over 70 genes. Many of these genes code for known virulence 
factors.
87
 The first class of small molecule AIs (AI-1) is primarily used for intraspecies 
communication in Gram-negative bacteria. AI-1 synthases use SAM as a substrate to 
produce a variety of acylhomoserine lactones (Table 1), with MTA as a byproduct. 
Pseudomonas aeruginosa utilizes AI-1 to regulate the production of several extracellular 
virulence factors, promote biofilm maturation, and regulate the expression of antibiotic 
efflux pumps.
51  
 
 
Figure 11. General scheme of a quorum sensing system. The signal synthase enzyme 
produces signal molecules, which reach the extracellular environment via diffusion or 
transport. At a critical signal molecule concentration, the signal binds to the receptor, 
which can be located in the cytoplasm (A) or at the cell surface (B). If the receptor is 
located in the cytoplasm, the signal-receptor complex activates or inactivates transcription 
of target genes. If the receptor is located at the cell surface, the signal sets off a 
phosphorylation signal transduction cascade that activates a transcriptional regulator at the 
end modulate target gene transcription. (adapted from Defoirdt et al., 2010).
97
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         Table 1. Bacterial Autoinducers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
The second class of small molecule AIs (AI-2) is considered a “universal” 
signaling molecule that allows inter-species communication.
46-48
 AI-2 is produced by the 
enzyme LuxS, which synthesizes 4,5-dihydroxy-2,3-pentanedione (DPD) that 
spontaneously cyclizes into a pro-AI-2 structure (Figure 9).
48,49
 In marine environments 
where boron is plentiful, pro-AI-2 spontaneously forms a boron diester structure (Table 
1).
 46,47,49
 However, a large number of bacterial species synthesize and respond to AI-2 in 
environments that may not contain boron, other derivatives of DPD exist. For some 
AI-3 
Farnesol 
AIP 
Autoinducer Molecule Autoinducer Type 
AI-2 
AI-2 
AI-1 
AI-1 
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species, the formation of DPD is purely a byproduct of metabolism.
47
 AI-2 has been 
shown to regulate biofilms and virulence factors in E. coli, as well as various other 
species (Table 2).
51, 76
  
Table 2. Autoinducer-2 Induced Effects 
 
There have been extensive investigations on the effects of luxS gene deletions, 
due to its direct connection with quorum sensing. Neisseria meningitidis luxS knockout 
strains were found to have reduced virulence.
44
 In other studies, luxS deficiency was 
found to alter sporulation in Bacillus subtilis, hemolysin secretion in Listeria 
monocytogenes, and twitching motility involved in colonization and biofilms in E. coli 
and Salmonella.
92 
An expanding list of other autoinducers has also been described. This includes 
autoinducer (AI-3), a molecule that is reported to have an epinephrine-like structure and 
may allow the bacteria to respond to host signaling molecules. In E. coli 0157:H7, AI-3 
appears to regulate the formation of attaching and effacing lesions.
67,86
 Lastly, microbial 
intercellular communication is not confined to bacteria, the isoprenoid farnesol is 
reported to act as an AI in the yeast Candida albicans.
88
 
 
Phenotype Bacterium 
Biofilms  E. coli, Helicobacter pylori, Pseudomonas 
gingivalis, Streptococcus gordonii,  
Streptococcus mutans 
 
Virulence Factors 
 
Clostridium perfringens, E. coli,  
Neisseria meningitidis,  
Pseudomonas gingivalis,  
Serratia marcescens,  
Streptococcus pyogenes, Vibrio cholerae   
 
Bioluminescence  
 
Vibrio fischerii, Vibrio harveyi 
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Biofilms 
In nature, the majority of bacteria are found within biofilms. Biofilms are 
composed of communities of bacterial cells that attach and proliferate on living or 
nonliving surfaces using a secreted extracellular polysaccharide matrix.
53
 This adhered 
communal existence allows bacteria to occupy a favorable microenvironment rather than 
simply being randomly dispersed. Thus, the traditional view of bacteria as existing solely 
as planktonic or free-swimming cells has now been replaced by the idea that the 
planktonic phase is simply a mechanism for translocation from one surface to another.
52
 
Many persistent and chronic bacterial infections are attributed to formation of biofilms in 
wound sites or on medical implants that resist antibiotic treatment and evade host 
immune responses.
54
 In addition, bacterial biofilms on food processing equipment and 
surfaces are a leading cause of food-borne illness.
53
  
Biofilm formation is a sequential process (Figure 12). In the first phase, the 
planktonic bacterial cells form a transient association with a new surface or to previously 
adhered microbes. Upon finding a suitable location, the bacteria progress from a transient 
association to form a microcolony. This colony may consist of one species or (more 
commonly) a heterogenous mix of species. At this stage, the cell density reaches levels 
that quorum sensing through AI molecules becomes feasible. The QS signaling pathways 
lead to altered gene transcription that stimulates production of an exopolysaccharide 
matrix that envelopes the micro-colony. Further alteration of gene transcription occurs to 
adapt the individual bacterial cell to communal existence within the biofilm. The 
modulation of biofilm unique genes includes the up-regulation of a wide array of 
enzymes and transporters, such as adaptive surface enzymes used to metabolize the chitin 
18 
 
from insects and crustaceans, and the creation of specialized nutrient transport channels 
within the matrix.
52,53
 In multispecies biofilms, bacteria establish micro-communities 
within the matrix that are optimized for both survival and symbiotic relationships 
between the groups of bacteria.
53
 In essence, a biofilm is not a random assortment of 
bacteria, but more akin to a developed city with defined architectures that allow a variety 
of optimal microenvironments to exist. 
Biofilms pose a major concern for the treatment of bacterial infections. The 
extrapolysaccharide matrix provides a shield against bacteriophages and amoebae, 
attenuates responses to antibiotics, and decreases access by the host immune system.
54,55
 
The thickness of the biofilm matrix prevents antimicrobial agent penetration to the full 
 
Figure 12. Biofilm maturation is a complex developmental process involving five 
stages. Stage 1: initial attachment; stage 2: irreversible attachment; stage 3: maturation I; 
stage 4: maturation II; stage 5: dispersion. Each stage of development in the diagram is 
paired with a photomicrograph of a developing P. aeruginosa biofilm. (adapted from 
Monroe, 2007).
84
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depth required to eliminate all of the microbes, and hinders phagocytosis by host 
neutrophils. Ultimately, this allows planktonic cells to escape and form other foci of 
infection 
54,55
 Since traditional antibiotics work to both eradicate pathogens and support 
host immune responses, these are much less effective in the context of biofilms.   
Escherichia coli O157:H7 
Enterohemorrhagic Escherichia coli O157:H7 is a pathogen often associated with 
foodborne illness. Infection can lead to devastating or life-threatening systemic 
manifestations such as hemolytic uremic syndrome (HUS) and hemorrhagic colitis 
(HC).
56
 The main cause of these serious ailments originates from the release of bacterial 
Shiga toxins (Stxs) during the infection, and subsequent damage to cells in the intestines, 
kidneys, brain, and other organs.
56
 While other serogroups of E. coli also produce Stxs, 
and are often more prevalent in humans, E. coli O157:H7 is especially virulent and 
responsible for the majority of HUS cases worldwide.
56,57
  
E. coli O157:H7 was first recognized in 1982 when an outbreak associated with 
contaminated hamburger occurred in the Jack-in-the-Box restaurant chain in Oregon and 
Michigan.
58
 Since then, sporadic outbreaks have occurred throughout the world. In 1998, 
a particularly large outbreak occurred in Japan, when over 9,000 children were infected.
59 
Symptoms of infection begin with severe cramps, initially followed by watery and 
then bloody diarrhea, with little or no fever.
60
 About 10% of cases develop into HUS, 
which carries a mortality rate of 2-10%.
57
 The most susceptible to the development of 
HUS are young children and the elderly.
60
 
The three principal routes of transmission are: fecal-contaminated food and water, 
person-to-person spread, and animal contact.
60
 The major animal carriers are healthy 
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cattle, and to a lesser degree other domesticated ruminants like sheep and goats.
56
 These 
animals act as reservoirs. E. coli O157:H7 is distributed through feces, which can 
contaminate foods when manure is used as a fertilizer or by direct contact during the 
slaughter and preparation of meat. Of these, contaminated meat, unpasteurized milk, and 
fecal-contaminated fruit and vegetables are the most common vehicles of transmission. 
However, undercooked ground beef is the major source of transmission accounting for 75 
out of 183 reported foodborne outbreaks in the US between 1982 and 2002.
57 
 
The production of two antigenically distinct forms of Stx (Stx1 and Stx2) by E. 
coli O157:H7 results in HUS and HC.
61
 Both toxins are compound toxins consisting of a 
catalytic A subunit and a cell targeting pentameric B subunit. 
56,57
 After entering the cell 
through receptor mediated endocytosis, the A subunit is proteolytically cleaved to yield 
the catalytically active RNA N-glycosidase. This enzyme cleaves specific bonds in the 
rRNA, preventing the binding of amino acyl-tRNA to the ribosome. This inhibits the 
elongation of the peptide chain during peptide synthesis and eventually leads to cell death 
(Figure 13).
61
 Ruminants lack the vascular Stx sensor, globotriaosylceramide. This allows 
them to act as E. coli O157:H7 carriers unaffected by Stx toxicity.
56
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The ability of Stx to produce attaching and effacing (A/E) lesions on a variety of 
cell types is one of the most important virulence characteristics found in E. coli O157:H7.
 
The A/E lesions can be described by degeneration and effacement of intestinal epithelial 
cell microvilli, intimate adherence of bacteria to the epithelial cell surface and bacterial 
 
Figure 13: Model for receptor mediated endocytic entry and processing of Shiga 
toxin in a mammalian cell. Shiga toxin enters the cell by receptor-mediated 
endocytosis. The B subunit of the toxin binds to the mammalian cell receptor 
globotriaosylceramide (Gb3). The clathrin-coated pit is pinched off, and the coated 
vesicle is formed. The vesicle is acidified, and may fuse with lysosomes. The A1 
fragment within the cytosol binds the 60S ribosome, leading to inhibition of protein 
synthesis and cell death. (adapted from O‟Brien et al., 1987).61  
 
22 
 
directed assembly of highly organized cytoskeletal structures in the host cells.
57
 These 
organized cytoskeletal elements form pedestal-like structures beneath the adhered E. coli 
O157:H7 cells and are a hallmark of this type of infection. Genetic studies have shown 
that the genes responsible for A/E lesions map to a region that is designated the locus of 
enterocyte effacement (LEE), and are considered a chromosomal pathogenicity island.
66
 
LEE is composed of at least 41 different genes, all required for bacterial adherence to the 
host cell.  
The mechanism of adherence to host cells is very complex and a multitude of 
factors play a role in the process. E. coli O157:H7, like many other Gram-negative 
bacteria, has a type III protein secretion system (TTSS), which is a complex surface 
structure used to deliver virulence proteins into the host cell (Figure 14).
62,63
 TTSS 
consists of a needle-like flagella that pierces the host cell to inject proteins that modify 
the membrane. The needle like flagella is comprised of multiple Escherichia secretion 
proteins (Esp) with EspA forming a filamentous structure on the bacterial surface that 
forms a bridge to the host cell; essentially the tip of the needle.
64
 EspB and EspD are 
injected through the needle into the mammalian cell membrane, where they form the end 
of the translocation complex required for other larger virulence factors to be injected 
directly into the host cell cytoplasm.
62, 63
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Adherence of E. coli O157:H7 to a mammalian cell is initiated by transfer of a 
translocated intimin receptor (Tir) into the host cell. Tir, much like EspB, becomes part 
of the mammalian cell membrane and provides a binding site for bacterial intimin. After 
this binding occurs, Tir links host actin fibers to the membrane to form the characteristic 
pedestal structure.
65
 This intimate binding allows other virulence factors to wreak havoc 
on the host cell, eventually leading to A/E lesions. 
The plasmid O157 (pO157) encodes for a myriad of additional virulence factors 
not found in the chromosomal DNA.
66
 The first described virulence factor of pO157 was 
 
Figure 14: A schematic of type III secretion structures in E. coli O157:H7. Type 
III secretion structures are composed of a needle-like complex (pink), which is 
anchored in the bacterial cell wall and a translocation complex (blue) in the host 
membrane. EspA (in green) extends from the tip of the needle and penetrates the host 
mucous barrier and thick glycocalyx reaching the underlying intestinal enterocytes. 
(adapted from He et al., 2004.)
63
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hemolysin, an endotoxin that lyses red blood cells by destroying their cell membrane 
through phospholipase activity. While hemolysin is not essential for producing either 
HUS or HC, the lysis of red blood cells provides iron for the pathogen that stimulates 
growth and production of other toxins.
57
 Other virulence factors encoded on pO157 are 
catalase-peroxidase, type II secretion proteins, serine protease, metalloprotease, and 
putative adhesion genes.
66 
  
Virulence regulation in O157:H7 has been attributed to luxS mediated quorum 
sensing (Table 3).
23,67
 The transcriptional regulation of genes in the LEE initiated through 
quorum sensing is complex since it consists of two regulators and multiple gene operons 
(Figure 15).
75
 The initial belief was that AI-2 controlled all aspects of virulence, but this 
was later disproved when luxS mutants were still able to produce A/E lesions in cultured 
epithelial cells.
67  
 
 
 
 
 
 
 
Further investigation determined that the genes for TTSS were AI-3 dependent, a 
signaling molecule that resembles epinephrine.
67
 Bacterial AI-3 receptors can also bind 
host cell produced epinephrine, thus providing a link between mammalian and bacterial 
communication pathways. It remains unclear whether the other aspects of virulence such 
as toxin production and biofilm formation are AI-2 or AI-3 dependent.  
Virulence Factor                                                                 Ref 
Biofilm production                                                               52 
Motility                                                                                86 
lee operons                                                                           80 
qse transcription                                                                   79 
Type III secretion                                                                 80 
Generation time                                                                    86 
Gene expression (404 genes)                                               86 
Table 3. Virulence factors affected by AI-2 in E. coli 
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Metabolomics and Proteomics of E. coli RK4353 
In recent years, liquid chromatography-tandem mass spectrometry (LCMS) has 
become an invaluable tool for the analysis of bacterial organisms. Extensive metabolic 
and proteomic analysis have been performed on a plethora of bacterial species to 
understand basic metabolism, and the changes to metabolism that occur in response to 
drug treatment, gene deletion, and changes in environment.
69
 This knowledge can be used 
to direct drug design by revealing new or additional targets.   
 
Figure 15. Model for luxS-dependent quorum sensing in enterohemorrhagic 
(EHEC) and enteropathogenic (EPEC) Escherichia coli. Interactions limited to 
EPEC are indicated by dashed lines. The histidine kinase QseC (quorum-sensing E. 
coli regulator C), together with its cognate response regulator QseB, activates the 
flagellar master operon flhDC (green boxes). Regulation of type III secretion (red 
boxes) is mediated through QseA, and indirectly through Ler. Together, the two 
proteins activate expression of five important lee operons that encode components of 
the type III secretion apparatus as well as adhesion proteins (intimin, Eae), the 
translocated intimin receptor (Tir), and other proteins. (adapted from Vendeville et 
al., 2005.)
76
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A pfs (MTN) gene knock-out strain was originally created in E. coli RK4353 to 
investigate potential gene polarization effects that occurred when deleting the gene 
encoding the periplasmic cobalamin-binding protein.
68
 While this Δpfs mutant was not 
created for the purpose of analyzing MTN deficiency, it has provided a nonpathogenic 
model system for these studies. A metabolite study of another nonpathogenic pfs knock-
out strain E. coli (MG1655) showed that it displayed up to 50% increases in SAM and 
SAH concentrations.
42
 While these data are interesting, neither of these strains allow the 
analysis of the effect of pfs gene deletion on virulence. However, these strains provide 
tools for proteomic analysis of adaptations to MTN deficiency, such as additional enzyme 
production or expression of enzymes used in potential alternate metabolic pathways.  
As mentioned previously, SAM is involved in radical reactions that produce 
vitamins that are required for enzymes to function properly. Inhibition of MTN would be 
expected to cause accumulation of inhibitory levels of 5‟dADO that in turn act to 
suppress the enzymes responsible for production of these vitamins.  This is a possible 
cause for the growth delays reported in various inhibition studies.
40,41
 Reduced vitamin 
production can be analyzed by comparing the activity of enzymes found in central carbon 
metabolism that require lipoate, thiamine, or biotin cofactors, such as the pyruvate 
dehydrogenase and α-ketoglutarate dehydrogenase complexes, in the MTN KO strain to 
the WT strain. The MTN KO strain could show differences in the activity of alternate 
metabolic pathways, such as lactate dehydrogenase or alcohol dehydrogenase, that are 
adapted due to MTN deficiency (Figure 16).  
27 
 
 
 
 
 
Figure 16. Central carbon metabolism with highlighted aspects affected by 
MTN deficiency. The specific enzymes or enzyme complexes of interest in this 
study are noted in red. Essential enzyme cofactors directly related to SAM radical 
reactions are highlighted in yellow.  
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Summary 
MTN is a critical enzyme required for bacterial metabolism and is a potential 
target of novel antibiotics. Inhibition of MTN causes accumulation of potent feedback 
inhibitory nucleosides that have significant effects on SAM metabolic pathways. The 
effects range from the disruption of quorum sensing to the lack of methionine salvage. 
While MTN inhibitors have shown limited bactericidal activity, they could be combined 
with other treatments to enhance antibiotic responses or improve host immune system 
removal of the bacterial infection.  
To fully understand the complete effects of MTN inhibition, genetic knockouts 
(MTN KO) of the pfs gene have been created in prior work.
42,43
 Removing the pfs gene 
allows for the maximal level of MTN inhibition and provides a standard to validate MTN 
as a drug target, and to use as a comparative tool to predict the effects of drug inhibition. 
All of the MTN KO strains have shown growth deficiencies, probably due to the 
inhibitory feedback effects of the nucleosides MTA, SAH, and 5‟dADO.5,42,43 Since 
MTN activity is responsible for directly producing the S-ribosylhomocysteine precursor 
for luxS dependent AI-2 synthesis, it is also probable that MTN deficiency will affect 
quorum sensing dependent events proposed to be involved in biofilm formation and 
virulence. 
In the following chapters, the potential of MTN inhibition as a target for antibiotic 
development have been investigated using a strain of pathogenic E. coli O157:H7. To 
understand how complete drug inhibition of MTN would affect this pathogen, a genetic 
knock-out of the pfs gene was created (MTN KO strain).  The WT and MTN KO strains 
were subject to a variety of analyses to establish the effects on growth, biofilm formation, 
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and virulence. Supplementation studies (with vitamins and autoinducer-2) were designed 
to explore the potential mechanisms of antibiotic action. Further investigations of 
metabolic enzyme activity in central carbon metabolism involved the use of a non-
pathogenic E. coli RK4353 MTN KO strain compared with its isogenic parental WT 
strain. For these studies, a directed investigation was performed on various enzymes that 
were predicted by proteomic data to be affected by MTN deficiency due to their 
dependence on vitamins for activity. Overall, the MTN KO strain showed defects in 
growth and virulence that appeared to be at least partially due to vitamin dependence. 
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CHAPTER TWO: MATERIALS AND METHODS 
Creation of Electrocompetent Cells 
E. coli O157:H7 strain (ATCC 43894) was streaked for isolation on LB plates and 
grown overnight at 37 °C. An isolated colony was used to inoculate 200 mL fresh LB 
media. Cells were grown at 37 °C at 225 RPM until the culture optical density at 600 nm 
(OD600) reached ~ 0.5. Cells were subsequently heat shocked for 10 minutes at 42 °C 
with shaking, followed by 15 minutes on ice with rotation. Cells were harvested by 
centrifuged at 8,000 xg for 15 minutes at 4 °C, and resuspended in 8 mL of ice cold 20% 
glycerol. The culture was split into eight 2 mL centrifuge tubes and centrifuged at 10,000 
xg for 1 minute. The supernatant was removed by aspiration, and the cell pellet washed 
three times with ice cold 20% glycerol. Competent cell pellets were resuspended in 50 l 
ice cold 20% glycerol and stored at -80°C. 
Generation of MTN Knockout (MTN KO) Strain Using the λ-Red System 
Deletion of the pfs gene was accomplished using the λ-red system.90 Briefly, the 
recombinase encoding plasmid pKD46 was introduced into competent cells using 
electroporation (2000 V, 200 Ω, and 25 μF). Following electroporation, samples were 
recovered in SOC media and incubated at 37 °C with horizontal shaking for 1.5 hours. 
Transformants were selected on LB plates supplemented with ampicillin (100 g/mL) 
and chloramphenicol (25 g/mL) plates and grown overnight at 37 °C. An isolated 
colony was selected and inoculated into 200 mL of fresh LB ampicillin (100 g/mL) 
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broth and grown at 37 °C until an OD600 of 0.1 was reached. Recombinase activity was 
induced by the addition of arabinose to 10 mM, and continued incubation at 37 °C until 
the culture reached an OD600 of 0.4. pKD46
+
 cells were made electrocompetent as 
described above.  
To create the MTN KO strain, the chloramphenicol resistance (Cm
r
) cassette in 
pKD3 was amplified by polymerase chain reaction (PCR) using primers containing 
flanking pfs homologous sequences: pfsLF-TTAGC CATGT GCCAG TTTCT GCACT 
AGTGA CTCAA CCATC AGTGT AGGCT GGAGC TGCTT CG-3‟; pfsLR-ATGAA 
AATCG GCATC ATTGG TGCAA TGGAA GAAGA AGTTA CGCTC ATATG AATAT 
CCTCC TTA-3‟ (pfs sequences are italicized). The PCR reaction contained 20 ng pKD3 
template, 50 pmol primer (each) and 1 unit One Taq Hot Start DNA polymerase (New 
England BioLabs, Ipswich, MA). Cycling conditions consisted of 95 °C (7 min), 
followed by 35 cycles of 94 °C (15 sec), 50 °C (30 sec), and 72 °C (90 sec).  The 1.1 Kb 
PCR product was purified using a Perfectprep® Gel Cleanup kit (Eppendorf, Hauppauge, 
NY) and quantified by UV spectrophotometry. The purified chloramphenicol cassette 
(100 ng) was introduced into competent E. coli O157:H7 cells containing pKD46 using 
the conditions described above. Successful transformants were selected on LB agar plates 
containing chloramphenicol (25 g/mL). The transformants (pfs, ampr, cmr) were cured  
(25 g/mL), but lacking ampicillin. Loss of MTN activity in the E. coli 0157:H7 strain 
(pfs, amps, cmr) was confirmed by enzyme assay and western blot analysis (see later 
section). 
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Generation of MTN Knock-In (MTN KI) Strain 
A MTN KI strain was created from the E. coli O157:H7 MTN KO strain in order 
to study the effect of gene reconstitution on the cellular phenotype.  The E. coli O157:H7 
(pfs, cmr) was made electrocompetent as described above. The plasmid pMTN29 was 
introduced using the electroporation conditions described for pKD46 (above), and 
positive transformants selected by growth on LB containing ampicillin (100 g/mL) and 
chloramphenicol (25 g/mL).  
Analysis of MTN Activity: Preparation of Bacterial Lysates  
Fresh 5 mL cultures of E. coli O157:H7 WT, MTN KO, and MTN KI strains were 
prepared in LB broth containing appropriate antibiotics and grown overnight at 37 °C 
with shaking. Cultures were diluted into 100 mLs of fresh LB broth and re-incubated for 
24 hours at 37 °C with shaking. Bacterial cells were harvested by centrifugation (5000 xg 
/ 15 min) and resuspended in 1 mL PBS. Cells were lysed by sonication on ice using a 
Misonix Sonicator 300 (power setting 7, 30 sec pulse, 1 min cooling, 2.5 min total 
sonication). The lysates were centrifuged at 5,000 xg for 15 min at 4 °C to remove debris, 
and the cell lysates transferred to fresh tubes. The protein concentration of the lysates was 
determined using BioRad reagent (BioRad, Hercule, CA). Lysates were stored at -80 °C 
until analyzed for MTN by immunoblot and enzyme assay. 
Analysis of MTN Activity: Immunoblot Assay 
The presence of MTN protein in the WT, MTN KO, and MTN KI strains was 
analyzed by SDS-PAGE and western blot. Samples of cell lysate proteins (20 g/lane) 
were electrophoresed (66 mA/45 min) on 15% acrylamide gels using a BioRad 
Miniprotean system. An EZ-Run Prestained Rec Protein ladder (Thermo Fisher 
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Scientific) was used as a standard to assess molecular weight. Separated proteins were 
transferred to nitrocellulose by electroblotting at 10V for 18 hours. The blot was blocked 
using 10x Superblock (Thermo Fisher Scientific) on a Millipore SNAP i.d. system. The 
presence of MTN in the lysates was detected using a murine monoclonal anti-MTN 
antibody
26
 (1:1000 dilution) and goat-anti-mouse Ig-HRP conjugate antibody (Thermo 
Fisher Scientific). Blots were developed using Pierce ECL Western Blotting substrate and 
Kodak X-Omat x-ray film.  
Analysis of MTN Activity: Enzyme Assay 
Activity of MTN in lysates of E. coli O157:H7 WT, MTN KO, and MTN KI 
strains was determined by monitoring loss of absorbance at 275 nm accompanying the 
cleavage of MTA into MTR and adenine using the extinction coefficient 1.6 mM
-1 
cm
-1
.
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The enzyme reactions contained 50 mM potassium phosphate (pH 7) and 100 µM MTA 
in a final volume of 990 µL, and were initiated by the addition of 10 µL (40 g) of lysate. 
The absorbance at 275 nm was measured using a Varian Cary 50 spectrophotometer. 
Specific activities were calculated in U/mg (1U = 1 mol/min MTA degradation).  
Cell Growth Assays 
To determine the effect of MTN status on growth, fresh overnight cultures of E. 
coli O157:H7 WT, MTN KO, and MTN KI strains were prepared in 5 mL Davis Minimal 
Media (per liter: 7 g KH2PO4, 2 g K2HPO4, 1 g (NH4)2SO4, 0.5 g Na citrate 2H2O, 0.025 
g MgSO4) supplemented with 0.2% glucose (DMMG). The overnight cultures were 
diluted 1:10,000 and 200 µL used to inoculate triplicate wells in a 96-well plate. The 
plate was incubated in a Synergy HT plate reader (BioTek, Winooski, VT) at 37 °C with 
shaking, and absorbance readings at 600 nm were taken every 15 minutes for 72 hours. 
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The assay was repeated with WT and KO strains with the DMMG medium supplemented 
with either lipoate, thiamine, biotin, dihydroxypentane dione (DPD), or a mix of all four 
supplements (1-100 µM).  
Biofilm Assays 
Cultures of the E. coli O157:H7 WT, MTN KO, and MTN KI strains were 
established in the 96-well plates as described for the cell growth assays above. Cultures 
were grown for 48 hours at 30 °C, which was optimal for biofilm formation. The media 
was then removed and the wells washed three times with PBS (250 µL) to remove 
loosely bound cells. Biofilms were fixed using 250 μL of a 1% paraformaldehyde 
solution in PBS for 1 hour at 4 °C. Subsequently, wells were washed three times with 
water, and the adhered biofilms stained with 250 L 0.1% crystal violet in PBS for 15 
min.
93
 Plates were washed three to five times with water, and the bound crystal violet 
solubilized in 250 L of an ethanol:acetone (80:20) solution for 15 min. Solubilized 
material (200 L) was transferred to a fresh 96-well plate and an absorbance reading at 
590 nm measured using a BioTek Synergy HT plate reader. The assay was repeated with 
WT and KO strains grown in DMMG supplemented with DPD, a vitamin mix (1 M 
each biotin, lipoate, thiamine), or DPD and a vitamin mix.  
A second assay was performed to more readily visualize biofilm production. 
Overnight cultures of the three strains were prepared as described above and diluted 
(1:10,000) into 3 mL of fresh DMMG in a 5mL polystyrene culture tube. Cultures were 
incubated for 48 hr at 30 °C. Biofilms were stained as describe above, with the 
modification that the volumes for all washing, fixing, and staining steps were adjusted to 
3.2 mL. Stained biofilms were photographed using a digital camera. The assay was 
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repeated with WT and KO strains grown in DMMG media supplemented with either 
DPD, vitamin mix, or DPD and vitamin mix as previously described.  
The qualitative appearance of biofilms formed by the three strains was also 
examined by confocal microscopy. Biofilms were grown on plastic coverslips partially 
submerged in 5 mL cultures in DMMG media. Biofilms on coverslips were washed and 
fixed as described above, but the volumes of solutions were adjusted to 5.5 mL for each 
step. After the final wash, the coverslips were stained with 1 mL 0.1% (w/v) acridine 
orange in PBS for 1 hour in the dark. Coverslips were rinsed lightly with PBS and the 
biofilms visualized at 600x magnification using a Zeiss LSM Meta 510 confocal 
microscope set to an excitation wavelength of 476 nm. Standard and Z-stack (20 slices) 
images were analyzed using Zen 2012 digital imaging software (Carl Zeiss Microscopy, 
Oberkochen, Germany).  
Adherence Assays 
The adherence of E. coli O157:H7 WT, MTN KO, and MTN KI strains to 
mammalian epithelial cells was studied using a previously established protocol.
94
 Briefly, 
bovine Mac-T epithelial cells were cultured in DMEM supplemented with 5% FBS, 
penicillin (100 U/mg), and streptomycin (100 g/mL) at 37 °C with 5% CO2. When cells 
were approximately 70% confluent, they were harvested and seeded in triplicate (~1 x 
10
5
 cells) onto coverslips in a 6-well plate. When cells on the coverslips were 
approximately 70% confluent, the coverslips were washed with antibiotic-free DMEM 
with 5% FBS. For adherence assays, E. coli O157:H7 WT, MTN KO, or MTN KI 
cultures were grown overnight in LB broth at 37 °C with shaking, and diluted (1:10,000) 
into DMEM. Cells were stained by addition of Syto-9 (10 g/mL) for 15 min, followed 
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by three washes with DMEM. Infections were initiated by addition of 1 mL bacterial 
cells (~1 x 10
6
 cells) to the surface of the mammalian cells. Co-incubation of bacterial 
and mammalian cells occurred for 3 hours at 37 °C with 5% CO2. The wells were then 
washed with PBS and the cover slips fixed with 4% paraformaldehyde in PBS for 10 min 
at room temperature. Coverslips were washed twice with PBS, permeabilized with 0.1% 
Triton X-100 in PBS for 5 min, and non-specific binding sites blocked with 1% BSA in 
PBS for 20 min. Cellular actin was stained with TRITC conjugated phalloidin dye (5 
μg/mL in PBS) for 40 min. Coverslips were washed twice with PBS, dried, treated with 
ProLong Gold antifade reagent (InVitrogen, Carlsbad, CA) and mounted on glass slides 
with clear nail polish. Adherent bacterial cells were visualized at 1000x magnification 
using a LSM Meta 510 confocal microscope with excitation wavelengths set to 348 nm 
(DAPI), 476 nm (Syto-9), and 557 nm (TRITC). Images were analyzed using Zen 2012 
digital imaging software (Carl Zeiss Microscopy, Oberkochen, Germany). 
To quantify bacterial adherence, bovine Mac-T cells were prepared as described 
above in a 6-well plate. Cultures were grown until they reached approximately 70% 
confluence, and then infected with WT, MTN KO, or MTN KI strain cells grown 
overnight in DMMG, DMMG supplemented with DPD (25 M), DMMG with vitamin 
mix (100 µM each lipoate, biotin, and thiamine), or DMMG with DPD (25 M) and 
vitamin mix (100 µM each). Co-incubation continued for 3 hours at 37 °C in 5% CO2 
atmosphere. Subsequently, bacterial cultures were aspirated, the wells washed three times 
with PBS, and the mammalian cells lysed by treatment with 0.1% Triton X-100 in PBS 
for 15 min. Dilutions of detergent lysates were plated onto LB agar, incubated overnight 
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at 37 °C, and the adhered cells enumerated by colony counting. Colony forming units 
(CFU) were expressed as a percentage relative to the adhered WT CFU (set at 100%). 
Vero Cell Cytotoxicity Assay 
Shiga toxin production was measured using a Vero cell cytotoxicity assay, 
essentially as described.
85
 To compare E. coli O157:H7 WT and MTN KO strain Shiga 
toxin production, cells were cultured overnight at 37 °C with shaking in 2 mL DMMG 
containing either: 1) no supplement; 2) 25 M DPD; 3) vitamin mix (100 M each 
lipoate, biotin and thiamine); or 4) a mixture of DPD and vitamin mix. To prepare 
secreted Shiga toxin samples, cultures were centrifuged at 15,000 xg for 5 minutes, and 
the supernatants filter sterilized and stored at -20 °C. The periplasmic Shiga toxin 
samples were prepared by resuspending the cell pellets in 250 L of polymyxin B (10 
mg/mL) in PBS.
95
 After shaking for 15 min at 37 °C, the samples were recentrifuged at 
15,000 xg for 10 min, and the supernatant (containing the periplasmic proteins) was 
removed, filter sterilized, and stored at -20 °C until assayed.  
Vero cells were cultured in DMEM supplemented with 5% FBS, penicillin (100 
U/mg) and streptomycin (100 g/mL) at 37 °C in 5% CO2 atmosphere. For cytotoxicity 
assays, Vero cells were seeded into 96-well plates at a cell density of 1 x 10
5
 cells per 
well 24 hr prior to exposure to toxin.  The media in each well was then replaced with 160 
µL antibiotic-free DMEM and 40 L of supernatant or periplasmic extract. All samples 
were tested in replicates of five. A positive control consisted of Vero cells exposed to 40 
L of ethanol. Negative controls (for cytotoxicity) consisted of untreated Vero cells, 
Vero cells treated with 40 L of sterile DMMG, or Vero cells exposed to 40 L of 
polymyxin B (10 mg/mL) in PBS. The plate was incubated for 48 hr at 37 °C in 5% CO2 
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atmosphere. The media was then removed, and cells stained for 30 min with 100 L of 
0.4% crystal violet in methanol. Excess dye was removed by rinsing the plate three times 
with distilled water. Bound dye was solubilized in ethanol:acetone (80:20) solution for 15 
min and the absorbance at 590 nm quantified using a BioTek Synergy HT plate reader. 
The percent cytotoxicity was calculated using the equation:  
                (
   
   
)      
where ODs is the difference in optical density at 590 nm between the sample and the  
negative controls, and ODt is the difference in optical density at 620 nm between the 
ethanol positive control and negative controls.  
Type III Secretion System Protein Assay 
The ability of WT, MTN KO, and MTN KI strains to secrete the type III secretion 
system proteins EspB and Tir was measured by the enzyme-linked immunoabsorbent 
assay (ELISA).
64
 Briefly, bacterial cultures were grown overnight in 10 mL M-9 minimal 
medium supplemented with 44 mM NaHCO2, 8 mM MgSO4, 0.4% glucose, and 0.1% 
casamino acids at 37 °C in 5% CO2 atmosphere.
64
 Cell culture supernatants were 
collected by centrifugation (10,000 x g/10 min) and concentrated 100-fold by 
ultrafiltration (Amicon Ultra 3K) according to the manufacturers specification. Samples 
were stored at -20 °C until assayed. 
ELISA plates were coated with 100 L concentrated cell culture supernatant in 
binding buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM 
MnCl2,) overnight at 4 °C. Wells were washed twice with PBS and blocked with 0.5% 
BSA in PBS for 1 hr at 37°C. EspB or Tir proteins were detected using monoclonal anti-
EspB or anti-Tir antibodies (kind gift of Dr. Brett Finlay at the University of British 
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Columbia) diluted 1:1000 in PBS + 0.05% Tween 20. After 1 hr in primary antibody, the 
ELISA plates were washed three times with PBS and incubated for an additional 1 hr 
with a horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody 
(Thermo Fisher Scientific) diluted 1:1000 in PBS + 0.05% BSA. Plates were washed 
three times with PBS and developed using horseradish peroxidase substrate (0.2 mg o-
phenylene diamine in an 50 mL 80 mM citrate–phosphate buffer, pH 5.0). Absorbance 
readings (490 nm) were collected for 30 min using a Biotek Synergy HT plate reader.         
Hemolysin Assays 
The amount of hemolysin produced by the WT, MTN KO and MTN KI strains 
was determined using a sheep red blood cell (SRBC) lysis assay.
91 
Briefly, bacterial 
cultures and cell culture supernatants were prepared as described above for secreted 
Shiga toxin. Serial dilutions of the cell culture supernatants were prepared in PBS and 
100 L added   to triplicate wells in a 96-well plate containing an equal volume of 3% 
SRBCs in PBS. The positive and negative controls consisted of SRBC lysis buffer (150 
mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA), and PBS, respectively. Plates were 
incubated at 37°C with shaking for 30 min. Absorbance readings at 620 nm were 
collected in a BioTek Synergy HT plate reader. Hemolysin activity was calculated using 
the following equation: 
            (
     
   
)      
where ODs is the difference in optical density at 620 nm between the sample and the 
SRBC lysis buffer positive control, and ODt is the difference in optical density at 620 nm 
between the PBS negative control and RBC lysis buffer positive control.  
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Metabolic Enzyme Analysis 
To analyze the effect of MTN deficiency on enzyme activities in central carbon 
metabolism, fresh 5 mL overnight cultures of the nonpathogenic E. coli RK4353 WT, 
MTN KO, and MTN KI strains were grown in DMMG at 37 °C with shaking. Overnight 
cultures were diluted into 500 mL of fresh DMMG for a total of six cultures per strain 
and incubated at 37 °C with shaking.  The cultures were monitored 
spectrophotometrically until the absorbance at 600 nm reached 0.5 (mid-log phase). At 
this point, three 500 mL cultures from each strain were centrifuged at 5000 xg for 10 min 
to pellet the cells. The supernatant was removed and the cell pellet was stored at -80 ºC. 
The remaining three cultures of each strain were cultured for 4 hours after reaching an 
absorbance (600 nm) of ~1.0 (stationary phase) and the cell pellets recovered by 
centrifugation at 5000 xg for 10 min. Cell pellets were extracted by vortexing in 5 mLs of 
B-PER bacterial protein extraction reagent (Pierce) for 15 minutes, and insoluble debris 
removed by centrifugation at 15,000 x g for 15 min. Lysate supernatants were removed 
and the protein concentration determined using a BioRad assay as described by the 
manufacturer Pyruvate dehydrogenase (PDH), lactate dehydrogenase (LDH), alcohol 
dehydrogenase (ADH), glutamate dehydrogenase (GDH), and  ketoglutarate 
dehydrogenase (KDH) activities in mid-log and stationary phase enzyme samples from 
the RK4353 WT, KO, and KI strains were measured using a colorimetric coupled assay 
and following the absorbance change at 570 nm.
96
 Enzyme reactions were assembled in a 
96-well plate, with each well containing 20 µL of a detection reagent (1 mM MTT, 150 
mM NAD
+
, 50 µM PES) and 170 µL of a substrate buffer (500 mM KPhos, pH 8.0, 10 
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mM MgCl2, 3 mM DTT) that contained either 50mM pyruvate, 1mM CoA (for PDHC); 
50 mM lactic acid (for LDH); 50 mM ethanol (for ADH); 50 mM glutamate (for GDH); 
or 50 mM α-ketoglutarate, 1 mM CoA (for KDH). Enzyme reactions were initiated by the 
addition of 10 µL of lysate. The increase in absorbance at 570 nm was measured every 30 
sec for 30 min using a BioTek Synergy HT plate reader. Average specific activities were 
calculated using the Beer-Lambert law (A=lc) using an extinction coefficient of 13 mM-
1 
cm
-1
. All reactions were run at least three times. The results were expressed in U/mg, 
where 1 U = 1 mol NADH created per min of mg of lysate protein.  
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CHAPTER FOUR: RESULTS AND DISCUSION 
Creation and Analysis of a Genetic MTN Knock-out in E. coli O157:H7 
Creation of the MTN gene knock-out strain of E. coli O157:H7 was achieved 
using the λ-red recombination system. The coding region for pfs (MTN) was replaced 
with a chloramphenicol resistance cassette (Figure 17). Successful transformation was 
difficult to obtain. Multiple attempts (> 10) to create the MTN KO failed. Probably this 
was due to the severe effect on growth caused by the MTN deletion. Eventually, an 
experiment resulted in two very small colonies surviving selection on chloramphenicol 
plates. Both colonies were repeatedly propagated under chloramphenicol selection to 
ensure gene deletion. Gene deletion was further confirmed by PCR (data not shown). The 
creation of a MTN knock-in strain was achieved by transforming the pMTN plasmid into 
MTN KO cells and selecting for ampicillin resistance. The resulting KI strain was MTN
+
 
Cm
r
 Amp
r
, and expressed MTN under the control of an IPTG inducible promoter.    
To ensure that the MTN KO strain had completely lost the ability to produce 
MTN, western blot and nucleosidase assays were performed (Figure 17). A monoclonal 
α-MTN antibody readily detected the 24.5 KD nucleosidase in western blots of cell 
lysates of the WT and MTN KI strains, but not in lysates of the MTN KO strain (Figure 
17 B). Similarly, MTA nucleosidase activity was detected in lysates of the WT and MTN 
KI strains. The MTN KO strain showed significant loss of nucleosidase activity relative 
to the WT strain (p<0.05). The residual enzyme activity in the MTN KO strain was at the 
limit of detection in the assay (Figure 17 C). While theoretically no MTN activity should 
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be present in the MTN KO strain, the small amount of substrate conversion in the assay 
could be due to solvent hydrolysis or the activity of nonspecific nucleosidases present in 
the lysate (e.g., AMP nucleosidase or purine nucleoside phosphorylase). 
 
 
 
 
 
   
 
 
 
     C  
 
 
 
 
 
 
 
 
 
Figure 17. Analysis of the E. coli O157:H7 MTN knock-out strain. (A) Representation 
of the dgt-pfs-butF-yadS region of the E. coli O157:H7 chromosome map. The Δpfs:Cm 
knockout strain was created by a 599 bp in-frame deletion of the pfs gene and insertion of 
the 1034 bp Cmr cassette. (B) Western blot analysis of MTN in WT, MTN KO, and MTn 
KI strains. MTN in cell lysates (20 μg protein/lane) was detected using a monoclonal 
mouse α-MTN antibody followed by staining with a goat α-mouse Ig-HRP conjugate.  
(C) Specific activities of cell lysates (40 μg protein /assay) were analyzed by UV enzyme 
assay (275 nm) using 100 μM MTA substrate. (1 U = 1 μmol/minute, n = 3, ± SEM) * 
denotes p<0.05 by 1way ANOVA.  
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Effect of MTN Deficiency on Growth 
MTN deficiency severely decreased growth rates in the MTN KO strain. This was 
initially evident in the small colony size of the MTN KO strain, and intermittent 
difficulty in growing overnight stock cultures in minimal media. In 96-well plate growth 
assays, an 18 hour delay in achieving mid-logarithmic phase growth was typically 
observed for the KO strain when compared to the WT (Figure 18 A). However, the MTN 
KO strain did eventually reach the same cell density as the WT culture. The MTN KI 
strain growth closely matched the WT strain. This indicates that the growth delay in the 
MTN KO strain can be attributed to the loss of MTN activity.  
Similar growth defects have been observed in other MTN KO strains constructed 
in the nonpathogenic E. coli RK4353
68
 and Neisseria meningitidis.
43
 In the initial report 
on the E. coli RK4353 MTN KO strain, investigators found a very strong reduction in 
growth in minimal media supplemented with methionine, and no growth in the absence of 
supplementation. These authors also reported that growth was restored in the MTN KO 
strain when it was transformed with a plasmid containing MTN.
68
 This finding is similar 
to the results we show in Figure 18 A (KI black dashed line). The Neisseria meningitidis 
MTN KO strain also showed similar growth deficiencies, even in nutrient rich medium. 
Growth was restored in the Neisseria MTN KO strain when the MTN gene was 
reintroduced on a plasmid.
43
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Figure 18. Comparison of growth of E. coli O157:H7 WT, MTN KO and MTN KI in 
Davis minimal media (A). Media was also supplemented with lipoate (B), thiamine, 
(C), biotin (D), DPD (E) and a mix of all the previous (F). Data shown is the average of 
three experiments with n = 3 replicates. 
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How loss of MTN activity caused growth delay in E. coli O157:H7 was probed by 
the addition of various vitamin supplements to the culture medium. Since MTN 
deficiency could result in an increase in 5‟dADO concentration that would subsequently 
cause feedback inhibition of radical SAM reactions involved in vitamin synthesis
10,82
, the 
effect of lipoate, thiamine and biotin supplementation on cell growth was explored 
(Figure 18  B, C, D). Of the three vitamins, lipoate supplementation showed the greatest 
effect on MTN KO strain growth. When MTN KO strain cultures were supplemented 
with 1 µM or 100 µM lipoate (Figure 18 B, gray dashed lines), the growth rate was 
dramatically improved and the time to achieve mid-log phase growth was shifted to 
within roughly 6 hours of the WT culture. Thiamine supplementation (1 µM or 100 µM) 
showed a less extreme effect on MTN KO strain growth with mid-log phase achieved at 
approximately 25 hours, or within 12 hours of WT growth (Figure 18 C, gray dashed 
lines). Lastly, biotin supplementation (1 µM or 100 µM) had the least effect on vitamin 
stimulated growth recovery in the MTN KO strain. Biotin supplemented cultures reached 
mid-log phase only 8 hours sooner than the unsupplemented MTN KO culture (Figure 18 
D, gray dashed lines).     
MTN gene deletion disrupts the primary pathway to AI-2 production by 
preventing hydrolysis of SAH to S-ribosylhomocysteine (SRH) that would block 
subsequent luxS mediated synthesis of DPD. While a second potential path to DPD 
synthesis has been reported, it was not found to be a significant source of AI-2 in E. 
coli.
81
 In addition, prior work in Neisseria and a nonpathogenic E. coli strain (RK4353) 
showed that MTN gene deletion abolished AI-2 production.
43,71
 To examine the potential 
role of AI-2 on E. coli O157:H7 growth, cultures of WT and MTN KO strains were 
47 
 
supplemented with DPD, the precursor to AI-2. DPD did not appear to improve growth 
rates in either the WT or MTN KO strain (Figure 18 E). These results are similar to those 
reported for N. meningitidis,
43
 and support the assertion that the observed growth defects 
are not autoinducer-2 dependent.  
In summary, the defects in planktonic cell growth due to MTN deficiency could 
largely be attributed to inhibition of radical SAM reactions that resulted in decreased 
LipA, BioB, and ThiH synthesis of lipoate, biotin and thiamine, respectively.
10
 However, 
culture supplementation with a mixture of all three vitamins and DPD failed to 
completely restore growth, suggesting that other deficiencies were also present in the 
MTN KO strain (Figure 18 F). Overall, the results of these growth studies suggest that 
MTN inhibitors could exert their antibiotic effect due to interruption of radical SAM 
reactions because of feedback inhibition by 5‟dADO. In addition, the observation that the 
MTN KO strain did eventually reach a culture density similar to the WT strain suggests 
that MTN inhibitors will behave in a bacteriostatic rather than bactericidal manner.  
Effects of MTN Deficiency on Biofilms 
When biofilm production was examined in a polystyrene-tube growth assay, 
obvious culture differences were observed by crystal violet staining (Figure 19 A).  The 
WT strain showed heavy biofilm growth, particularly at the liquid-air interface. The 
MTN KO strain showed little crystal violet staining. Culture supplementation with DPD 
failed to restore biofilm growth. Similar to the planktonic growth studies, vitamin 
supplementation (100 µM lipoate, thiamine, biotin) restored MTN KO biofilms to 
approximately WT levels. The reduction in biofilm due to MTN KO was further 
quantified in a 96-well plate assay. Wells containing 48 hour cultures of WT and MTN 
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KO cells (+/- supplementation) were stained with crystal violet and the biofilms 
quantified by measuring the spectrophotometric absorbance at 595 nm. The results 
showed that biofilms were reduced by greater than 80% in the MTN KO strain when 
compared to the WT strain (Figure 19 B). Again, vitamin supplementation restored MTN 
KO biofilms, whereas the addition of DPD did not.  
 
The effect of MTN KO on E. coli O157:H7 biofilm formation was also examined 
by confocal microscopy (Figure 20). In these studies, biofilms were grown directly on 
plastic cover slips and visualized by staining with acridine orange. As the figure shows, 
the WT and MTN KI strains formed heavy biofilms (Figure 20 A). By comparison, the 
MTN KO strain formed only a weak disperse biofilm. Three dimensional pictures created 
from serial images through the depth of the biofilm further show the mature architecture 
       A    WT                       KO                       _    
          No Tx    No Tx     DPD        Vit     DPD+Vit 
 
              B 
 
Figure 19. Comparison of biofilm production by E. coli O157:H7 WT and 
MTN KO strains. (A) Crystal violet staining in 48 hour biofilms grown in minimal 
media. MTN KO cultures were supplemented with 25 µM DPD, 100 µM vitamin 
mix (Vit), or DPD and vitamin mix (DPD + Vit). (B) Quantitative data of crystal 
violet stained biofilms (± SEM, n = 3).* denotes p < 0.05 by One-way ANOVA 
* 
* 
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of the WT and MTN KI strain biofilms (Figure 20 B). Biofilm formation in the MTN KO 
was too weak to assemble a three dimensional image.     
 
Previous work has demonstrated the disruption of E. coli O157:H7 biofilms using 
MTN inhibitors.
71
 However, biofilm formation was only reduced by 18% when compared 
to the untreated control. Potentially this modest effect on biofilms could be attributed to 
poor drug permeability into the E. coli cells. On the other hand, the same drug treatment 
caused a 70% reduction in Vibrio cholera biofilms.
71
 Overall, our studies indicate that 
biofilm formation in E. coli O157:H7 is dependent on the availability of vitamins used by 
metabolic enzymes, rather than AI-2 signaling. In this regard, the reports in the literature 
                         WT                           KO                      KI 
 
Figure 20. Confocal microscopy of biofilms produced by E. coli O157:H7 WT, MTN 
KO, and MTN KI strains. Biofilms were grown for 48 hours on plastic coverslips and 
stained with acridine orange. (A) Images taken at 630x magnification. (B) 3-D images 
created from Z-stacks at 630x magnification. Biofilms were insufficient in the MTN KO 
strain to create a 3-D image. 
A 
B 
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of the effects of AI-2 on biofilm formation are not consistent. For the majority of these 
studies, luxS KO strains were examined since they are unable to make DPD, the precursor 
to AI-2.
 72-75 
The loss of biofilm formation seen in the luxS KO strains was attributed to 
lack of AI-2 signaling, but nutrient supplementation was not investigated. In one study, 
supplementation of WT E. coli O157:H7 with DPD increased biofilm formation by 30-
fold.
72
 In our studies, DPD treatment did not cause an increase in WT biofilms (not 
shown). However, the abundant biofilms formed by the WT strain we studied may have 
masked any overt influence by DPD, and we did not examine early stages of biofilm 
formation. 
Effect of MTN Deficiency on Virulence Factors 
Adherence 
The effect of MTN deficiency on virulence was initially examined by comparing 
the ability of the WT and MTN KO strains to adhere to mammalian cells. Cows are the 
main reservoirs for E. coli O157:H7, thus the ability of the bacteria to adhere to cultured 
bovine epithelial cells was measured. Using confocal microscopy, the adherence of the 
WT strain to the surface of bovine Mac-T cells was readily apparent (Figure 21 A). To 
find adherent MTN KO cells was difficult, as these events were visible on fewer than 1 in 
50 microscopic fields (Figure 21 B).  
Microbial adherence was also measured by counting colony forming units (CFUs) 
after bacteria were incubated with bovine Mac-T cell cultures. In these experiments, 
bacterial cells were added to the mammalian cell culture at an MOI of ~100. Adhered 
bacterial cells were liberated following detergent lysis of the mammalian cell culture and 
enumerated by counting the colonies that appeared on LB agar plates. As the graph in 
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Figure 14 C shows, the MTN KO strain exhibited an 85% decrease in adherence to 
bovine Mac-T cells relative to the WT strain. Similar results were obtained when the 
experiment was performed with the human HeLa cell line (not shown). There are no 
other reports of adherence studies using MTN KO strains. However, the adherence and 
infectivity of luxS mutants has been studied.
43,77
 Epithelial cell adherence was reported to 
be reduced by two orders of magnitude in a luxS mutant strain of enteropathogenic E. coli 
(EPEC).
77 
In the pathogen N. meningitidis, luxS mutants were attenuated for the ability to 
cause  bacteremia in mice.
43
 These studies established that loss of AI-2 synthesis 
decreased bacterial virulence. They suggest that interruption of MTN activity could 
similarly be expected to reduce virulence since AI-2 is also not made in the MTN KO 
strain.  
Since nutrient supplementation caused profound effects on bacterial growth and 
biofilm production, the effect of similar supplementation was studied in the mammalian 
cell adherence assay. Overnight culture of the bacterial cells with either DPD (25 µM), 
vitamin mix (100 µM each lipoate, thiamine, biotin), or both (DPD + Vit) failed to 
improve adherence of the MTN KO strain to Mac-T cells (Figure 21 C). This data 
indicates that adherence is not due to AI-2 signaling or vitamin dependent metabolism. 
Other studies suggest that E. coli O157:H7 adherence is influenced by AI-3 rather than 
AI-2 signaling.
67
 In general, the conflicting reports of the effect of AI-2 signaling on 
bacterial adherence and virulence underscores the complexity of these processes. The 
failure of culture supplementation with DPD and vitamins to reverse the loss of 
adherence to mammalian cells by the MTN KO strain suggests that other factors (e.g., 
specific methylations, polyamines, etc.) are required for this event.  
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Figure 21. Analysis of E. coli O157:H7 WT and MTN KO strain adherence to 
bovine Mac-T cells. Confocal microscopy images of WT (A) and MTN KO (B) 
adherence to Mac-T cells. Bacteria were stained for nucleic acid (green). Mac-T cells 
were stained for actin (red) and nuclei (green). Bacterial adherence to Mac-T cells 
were determined as the CFU recovery compared to WT 3 hours post infection. MTN 
KO cultures were supplemented during growth with DPD, vitamin mix, or DPD and 
vitamin mix (* denotes p <0.05 when compared to WT, ± SEM, n = 3) 
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Shiga Toxin 
One of the most deadly aspects of an E. coli O157:H7 infection is the high risk of 
developing HUS due to Shiga toxin-mediated damage to kidney endothelial cells. To 
better understand how MTN inhibitors may influence this type of virulence, the 
production of Shiga toxins in WT and MTN KO strains were compared using an African 
green monkey kidney epithelial (Vero) cell assay. Shiga toxin 1 (Stx1) is primarily found 
in the periplasmic space, whereas Shiga toxin 2 (Stx2) is secreted into the media.
70
 Shiga 
toxin levels in cell culture supernatants and periplasmic extracts were compared for each 
strain. A significant decrease in cytotoxicity (~60%) was observed for culture 
supernatants derived from the MTN KO strain when compared to the WT strain (Figure 
22 A). Culture supplementation with DPD (25 µM) alone was insufficient to reverse the 
loss of cytotoxicity. When the MTN KO strain culture was supplemented with either 
vitamin mix (100 µM each lipoate, thiamine, biotin) or DPD and vitamin mix (DPD + 
Vit), Shiga toxin mediated cytotoxicity was restored to WT levels. No significant 
difference was seen for Vero cell cytotoxicity in the periplasmic extracts from each strain 
(Figure 22 B). To ensure that differences in cytotoxicity in the assay were not masked by 
saturating levels of toxin, the assay was performed using a series of periplasmic extract 
dilutions. In general, the MTN KO strain retained more Shiga toxin activity in the 
periplasm than the WT strain (Figure 22 C).  Culture supplementation did not result in 
more Shiga toxin release from the periplasm. Our results show that the MTN KO strain is 
still producing both Stx1 and Stx2. The increased level of periplasmic Stx in the MTN 
KO strain could be the result of increased expression of Stx-1 or decreased secretion of 
Stx-2. The effect of MTN interruption on Stx expression appears to be connected to the 
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nutrient status of the cells, rather than AI-2 signaling. Overall, our results suggest that 
MTN inhibitors could exert their antibiotic effect through decreased Shiga toxin release 
as one mechanism of action.  
 
 
      
Figure 22. Effect of MTN deficiency on Shiga toxin production in E. coli O157:H7. 
Comparison of Vero cell cytotoxicity when treated with (A) culture supernatants and (B) 
periplasmic extracts of WT and MTN KO strains. Cultures were supplemented during 
growth with DPD, vitamin mix, or DPD and vitamin mix. (C) Vero cell cytotoxicity 
measurements using a dilution series of periplasmic extract. (* denotes p <0.05 when 
compared to WT, ± SEM, n = 3). 
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There have been no prior reports of Stx production in MTN KO strains. However, 
a luxS deficient strain of E. coli O157:H7 was reported to secrete approximately two-fold 
less Stx.
85
 Despite this, the virulence of the strain in mice was not altered. Similarly, a 
luxS mutant of Clostridium perfringens produced reduced amounts of alpha-, kappa-, 
theta-toxins when compared to the WT strain.
78
 Unfortunately, in these reports, the effect 
of AI-2 or nutrient supplementation was not explored so it is difficult to assess if the 
results were due to loss of AI-2 signaling or nutrient salvage. In any case, luxS deficiency 
would not result in the same accumulation of inhibitory nucleosides like the MTN KO 
strain. Thus, the effects of luxS deficiency do not necessarily predict the same responses 
that would be encountered with loss of MTN activity. 
Type III Secretion System Proteins 
E. coli O157:H7 produces a multitude of other virulence factors that contribute to 
its pathogenicity. The LEE pathogenicity island encodes many of these virulence factors, 
including those that are required to assemble the type III secretory system (TTSS).
76
 
Secretion of two specific TTSS proteins, EspB and Tir, by WT, MTN KO and MTN KI 
strains was analyzed by ELISA (Figure 23 A, B). EspB is a major constituent of the 
TTSS pore, while Tir is translocated through the pore into the host cell where it mediates 
subsequent bacterial adherence and pedestal formation. The MTN KO strain showed a 
significant decrease (20%) in EspB secretion when compared to the WT strain. EspB 
production was recovered to WT levels in the MTN KI strain. No significant difference 
was seen for the secretion of Tir. The decreased production of EspB in the MTN KO 
strain could result in decreased pore formation that would reduce Tir delivery to the host 
cell. This could be responsible for the decreased host cell adherence displayed by the 
56 
 
MTN KO strain (Figure 23). However, the modest decrease in EspB is likely not 
sufficient to account for all of the loss in adherence shown by the MTN KO strain. The 
TTSS contains numerous other proteins required for host cell adherence. A 
comprehensive investigation of the entire system is required before the effect of MTN 
deficiency on TTSS can be fully understood.  
The TTSS has not been previously studied in MTN KO strains.  The effects on 
TTSS proteins have been studied extensively in luxS mutants of E. coli 
O157:H7.
66,76,78,79,80,83
 In these studies, LEE transcription was decreased in the luxS 
mutants. Similar to our observations on the MTN KO strain, the luxS mutants showed a 
minimal ability to adhere to mammalian cells.
76
 Western blot analysis of the luxS mutants 
revealed decreased expression of TTSS proteins, including EspA, EspB, and Tir 
responsible for the loss of mammalian cell adherence.
66,76,78
 It is unclear why there are 
differences in expression of Tir between the MTN KO and luxS mutant strains. However, 
the results suggest that additional factors beyond AI-2 signaling are involved in gene 
expression from the LEE. 
 
Hemolysin 
The final virulence factor that was investigated in this study was hemolysin. The 
function of hemolysin is to lyse red blood cells, which allows the bacteria to harvest the 
liberated iron. Hemolysin secretion by WT, MTN KO, and MTN KI strains was 
measured by examining the ability of cell culture supernatants to lyse sheep red blood 
cells. The results are expressed as a percentage of the control detergent lysis (100% 
control). The MTN KO strain showed a significant decrease (33%) in hemolysin activity 
relative to the WT and MTN KI strains (Figure 23 C). A similar finding was reported in a 
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luxS mutant strain of Serratia marcescens, where production of secreted hemolysin was 
reduced when compared to the WT strain. In addition, the investigators were able to fully 
restore hemolysin production by expression of luxS in trans.
73 
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Figure 23. Comparison of virulence factor production in E. coli O157:H7 WT, MTN 
KO, and MTN KI strains. (A) ELISA analysis of secreted EspB. (B) ELISA analysis of 
secreted Tir. (C) Analysis of secreted hemolysin activity. (* denotes p <0.05 by one-way 
ANOVA, ± SEM, n = 3). 
 
* 
* 
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Overall, the MTN KO strain showed a significant decrease in virulence when 
compared to the parental WT strain. This provides support to the hypothesis that MTN 
inhibitors could act as to regulate virulence rather than directly kill bacterial cells. In 
reducing the ability of the pathogen to produce virulence factors, MTN inhibitors could 
improve the ability of the host immune system to clear infections.  
Metabolic and Proteomic Analysis of E. coli RK4353 
Prior work in our lab used nuclear magnetic resonance to examine the profiles of 
excreted metabolites in cell culture supernatants of the nonpathogenic E. coli RK4353 
WT, MTN KO, and MTN KI strains.  Metabolite differences were observed at mid-log 
and stationary phases of growth. The most notable differences were the accumulation of 
pyruvate (4.8 mM), lactate (0.5 mM) and glutamate (3.6 mM) in the culture supernatants 
of the MTN KO strain, while these compounds are scarcely detectible (<0.1 mM) in the 
WT and MTN KI strains.  In addition, the WT and MTN KI strain cultures accumulated 
ethanol (0.4-0.5 mM) and acetate (4-5 mM), which are both products of vitamin 
(thiamine, lipoate) dependent fermentation of pyruvate. The MTN KO strain did not 
accumulate these compounds to the same degree (<0.1 mM ethanol; 2 mM acetate).  
These results suggested that there are defects in vitamin dependent central carbon 
metabolism in the MTN KO strain.  Specifically, the pyruvate dehydrogenase complex 
(PDHC, lipoate-, thiamine-dependent) at the end of glycolysis and the -ketoglutarate 
dehydrogenase complex (-KDHC, lipoate-, thiamine-dependent) in the tricarboxylic 
acid cycle both appear to be attenuated in their activity. Thus, pyruvate accumulates in 
the MTN KO strain culture, or is converted through the non-vitamin dependent lactate 
dehydrogenase (LDH) to yield lactate. Reduced metabolic flux through -KDHC would 
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lead to -ketoglutarate being converted to 2-oxoglutarate and finally to glutamate 
through the non-vitamin dependent glutamate dehydrogenase pathway. The results of 
these studies served as the basis for our hypothesis that altered metabolism in the MTN 
KO strain is attributable to decreased radical SAM dependent vitamin synthesis.  Since 
central carbon metabolism ultimately controls the ability to produce energy through 
oxidative phosphorylation, altered metabolism would impact growth. 
Cell culture supernatants of the MTN KO strain also accumulated MTA (3-6M), 
indicating that the nucleoside was getting secreted as a mechanism to prevent 
intracellular accumulation of this growth inhibitory nucleoside. As expected, MTA was 
absent from the WT and MTN KI strain culture supernatants, since the nucleosidase 
would function to efficiently catabolize the compound in these strains.  
Proteomic analysis of the three nonpathogenic E. coli strains (WT, MTN KO, and 
MTN KI) was conducted at Pacific Northwest National Labs using Liquid 
Chromatography-Tandem Mass Spectrometry (LCMS).  While not directly part of the 
thesis work, some of the results are presented here since they provide the rationale to 
support our subsequent comparison of enzyme activities in the WT, MTN KO, and MTN 
KI strains. The results of proteomic analysis are presented in Table 4. The MTN KO 
strain appears to express more PDHC and LDH proteins than the WT strain. The WT 
strain produced more -KDHC and glutamate dehydrogenase than the MTN KO strain. 
However, a direct correlation between the protein expression and the results of the NMR 
analysis was not supported. It is possible that the vitamin dependent enzymes were 
overexpressed in the MTN KO strain, but not functionally active due to decreased 
vitamin synthesis in this strain.  
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To further investigate the results of the metabolic and proteomic experiments, 
multiple enzyme assays were performed.  The PDHC specific activity of the cell lysate 
supernatants from the MTN KO strain was greatly diminished when compared to the WT 
strain (Figure 24 A). This would explain the accumulation of pyruvate in the MTN KO 
cell culture supernatants. When enzyme assays containing MTN KO cell lysates were 
supplemented with lipoate and thiamine, the PDHC activity was fully recovered. This 
supports our earlier findings that radical SAM-dependent vitamin synthesis was deficient 
in the MTN KO strain. Theoretically, the same situation should arise in α-KDHC as in 
PDHC, but we were unable to detect α-KDHC activity. 
Table 4. Proteomic Differences in the WT and KO strains of E. coli RK4353  
Protein Identification and Purpose Fold Change*    p-value   
ADH-Alcohol Dehydrogenase      Mid-Log  Stationary  Mid- Log  Stationary 
mhpF [acetaldehyde-CoA dehydrogenase II] -3.8 -2.7 0.013 0.012 
adhE [acetaldehyde: alcohol dehydrogenase] 1.1 1.3 0.642 0.337 
PDHC-Pyruvate Dehydrogenase Complex     
aceE [pyruvate dehydrogenase, decarboxylase  
          component E1] -1.8 -1.7 0.054 0.061 
aceF [pyruvate dehydrogenase, dihydrolipoyltransacetylase                            
c        component E2] -2 -1.9 0.022 0.037 
lpd [lipoamide dehydrogenase] -1.6 -1.7 0.004 0.023 
LDH- Lactate Dehydrogenase     
ldhA [fermentative D-lactate dehydrogenase] -3.3 -3.4 0.05 0.291 
αKDHC-α-Ketoglutarate Dehydrogenase Complex     
sucB [dihydrolipoyltranssuccinase\ subunit of α-ketoglutarate 
DH] 1.4 -1.2 0.045 0.608 
GDH-Glutamate Dehydrogenase     
gdhA [glutamate dehydrogenase] 1.2 1.2 0.478 0.565 
* Negative values denote expression is higher in the KO strain than in the WT strain. Positive values denote 
a lower expression in the KO strain than the WT strain. 
The MTN KO strain appears to adapt to decreased PDHC and α-KDHC by 
directing pyruvate and α-ketoglutarate down alternate metabolic paths. Pyruvate 
conversion to lactate is increased since LDH activity does not require vitamins. However, 
the increased flux through LDH did not require additional enzyme activity (Figure 17 B). 
Similarly, glutamate production was increased in the MTN KO strain, but increased GDH 
activity was not seen (Figure 24 D).  
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Lastly, while ethanol excretion was increased in the WT strain, this was not the 
result of increased ADH expression (Figure 24 C). Probably, the increased metabolic flux 
through ADH was the result of increased vitamin dependent pyruvate decarboxylase in 
the WT strain that subsequently increased the concentration of acetaldehyde substrate for 
ADH. In summary, the results of our analyses of metabolic enzymes indicate that loss of 
radical SAM-dependent vitamin synthesis plays a major role in metabolic adaptations in 
the MTN KO strain.  
 
 
C 
 
 
 
 
 
Figure 24. Analyses of the specific activities of enzymes affected by MTN deficiency in 
E. coli RK3453. (A) Pyruvate dehydrogenase complex, (B) lactate dehydrogenase, (C) 
alcohol dehydrogenase and  (D) glutamate dehydrogenase specific activities were measured 
by a colorimetric assay using cell lysates from the WT, MTN KO, MTN KI strains. The 
specific activity of the KO strain was supplemented with lipoate and thiamine was also 
measured for the pyruvate dehydrogenase complex. (* denotes p <0.05 when compared to 
WT, ± SEM, n = 3) 
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Future Work 
The work following this thesis will consist of metabolomic and proteomic 
analyses of the WT and MTN KO strains of E. coli O157:H7. Initial studies will compare 
this pathogenic strain to the data obtained from the nonpathogenic RK4353 strain. 
Analysis of various virulence factors will also be performed. Another goal is to discover 
other adaptations to MTN deficiency that can be identified as drug targets. The WT and 
KO strain of E. coli O157:H7 will be subjected to an array of enzyme assays to further 
support data found in the proteomic studies. In tandem with the LCMS analysis of 
virulence factors, real-time PCR investigations will be performed to understand MTN 
deficiency on mRNA expression. This will ultimately provide a complete understanding 
of MTN deficiency in a pathogenic strain of bacteria and serve as a standard comparison 
for MTN inhibitors. 
Once the profile of MTN deficiency is established, the work will shift to testing 
various MTN inhibitors against the WT E. coli O157:H7 strain and on other bacterial 
species. In addition to sole inhibitor analysis, co-treatment studies with traditional 
antibiotics and MTN inhibitors will be performed to examine potential drug synergy. 
Various bacterial species that have developed resistance to most antibiotics, such as 
MRSA, will be treated with MTN inhibitors to determine if drug resistance can be 
reversed. The ultimate goal will be to test MTN inhibitors as antibiotics to treat infections 
in mammals (i.e., mice). This testing would provide the results needed to further pursue 
MTN inhibitors as antibiotic treatments in humans.  
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CHAPTER FOUR: CONCLUSION 
Antibiotic resistance is a serious problem and eventually all forms of bacteria may 
become resistant to traditional antibiotics, thus making every infection potentially deadly. 
Due to this threat, there is a dire need for novel forms of antibiotics. A promising 
antibiotic target is the bacterial-specific MTN enzyme. Loss of this critical enzyme in a 
MTN KO strain of the pathogenic E. coli O157:H7 has been shown in this work to result 
in a significant delay in growth and reduce multiple aspects of virulence. Specifically, 
adherence to bovine epithelial cells was reduced by over 85% compared to the WT strain. 
The MTN KO strain also displayed a 60% reduction in Shiga toxin mediated cytotoxicity. 
Furthermore, the reduction in adherence could be partially attributed to the diminished 
production of TTSS proteins, in particular EspB.  
Supplementation studies with DPD indicated that the alterations to growth and 
virulence were not due to loss of AI-2 signaling. When the MTN KO strain culture was 
supplemented with vitamins (lipoate, thiamine, and biotin) growth and biofilm formation 
was partially restored to WT levels. This suggests that the antibiotic mechanism of action 
for MTN inhibitors partially occurs through altered central carbon metabolism or 
decreases in other vitamin dependent enzyme activity. Further metabolomic and 
proteomic investigation of a nonpathogenic E. coli RK4353 strain revealed adaptations to 
MTN deficiency. Specific analyses of enzymes key to central carbon metabolism found 
an overproduction of a defective PDHC, whereas specific activity for LDH, ADH, and 
GDH were unchanged. The activity of the defective PDHC was restored with the addition 
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of lipoate and thiamine, further supporting that MTN deficiency disrupts vitamin 
synthesis. This study as a whole serves as the foundation for future investigations of 
MTN inhibitors as potential antibiotics.   
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